Electric impedance microflow cytometry for characterization of cell disease states by Du, E. et al.
Electric Impedance Microflow Cytometry for Characterization of
Cell Disease States†
E Du#a, Sungjae Ha#b, Monica Diez-Silvaa, Ming Dao*,a, Subra Suresha, and Anantha P.
Chandrakasan*,b
aDepartment of Materials Science and Engineering, Massachusetts Institute of Technology, 77
Massachusetts Avenue, Cambridge, MA 02139, USA
bDepartment of Electrical Engineering and Computer Science, Massachusetts Institute of
Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA
#
 These authors contributed equally to this work.
Abstract
The electrical properties of biological cells have connections to their pathological states. Here we
present an electric impedance microflow cytometry (EIMC) platform for the characterization of
disease states of single cells. This platform entails a microfluidic device for a label-free and non-
invasive cell-counting assay through electric impedance sensing. We identified a dimensionless
offset parameter δ obtained as a linear combination of a normalized phase shift and a normalized
magnitude shift in electric impedance to differentiate cells on the basis of their pathological states.
This paper discusses a representative case study on red blood cells (RBCs) invaded by
Plasmodium falciparum malaria parasites. Invasion of P. falciparum induces physical and
biochemical changes on the host cells throughout a 48-h multi-stage life cycle within the RBC. As
a consequence, it also induces progressive changes in electrical properties of the host cells .We
demonstrate that the EIMC system in combination with data analysis involving the new offset
parameter allows differentiation of Pf–invaded RBCs from uninfected RBCs as well as among
different P. falciparum intraerythrocytic asexual stages including the ring stage. The
representative results provided here also point to the potential of the proposed experimental and
analysis platform as a valuable tool for non-invasive diagnostics of a wide variety of disease states
and for cell separation.
Introduction
Electric impedance spectroscopy (EIS) is a well established technique and has been widely
utilized in the development of various biosensors.1 This method offers a complementary
technique for in-vivo detection of a variety of cancers including malignancy in the liver,2
bladder,3 skin4 and breast.5 For in-vivo EIS-based detection, the detectability and spatial
resolution of lesions are highly limited by the contrast ratio of the focal region and its
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surroundings.6 The electric impedance (EI) of the malignant tissues measured by EIS is
relatively lower compared to those of normal tissues over radio frequency range.
Similarly, at the cellular level, variation in electrical properties of cells may be linked to the
biochemical changes introduced by disease pathology. This variation can be detected
through electrical impedance (EI) sensing of cell-substrate interactions, which was initiated
by Giaever and Keese in 19847. This method has been widely utilized to monitor cellular
response to various stimuli, such as drug treatment,8 infection by malaria parasite,9, 10 and
proliferation of leukaemia cells,11 and to detect molecular or cell bounding events (through
interactions of antibody-antigen, proteins, enzymes, etc.) such as those involving influenza
virus12 and breast cancer cells.13 This method usually requires immobilization of a bio-
recognition element on the surface of sensing electrodes or detection sites for enhanced
specificity and signal amplification. Further recent developments include single-cell EI
sensing systems utilizing microfluidic flow control in combination with microfabricated
electrode structure,14-16 which ensures high detection sensitivity as variations in electric
current flow induced by the perturbation from cellular presence or biochemical interactions
occur adjacent to sensing electrodes. Single-cell EI has been demonstrated to be an effective
strategy for cell counting,17 discrimination of various cell lines such as monocytes from
dendritic cells and fibroblasts from adipocytes,18 and detection of Babesia bovis-infected
bovine red blood cells (RBCs).19 Systematic modelling and simulation of the single-cell EI
was conducted to link the dielectric properties to the cellular impedance response.20 For
parasitic diseases, EI sensing relies on the changes in electrical properties of cytoplasm and
cell membrane, as the variation resulting from size changes of infected cells is negligible.
Diagnosis of malaria, an infectious disease threatening human health, relies on detection and
counting of infected red blood cells (iRBCs). There were an estimated 216 million episodes
of malaria and an estimated 655,000 malaria deaths in 2010, of which 91% were in Africa.21
Among five types of Plasmodium infecting humans, Plasmodium falciparum is the deadliest
strain causing malaria.22 P. falciparum infection not only alters the membrane permeability
of the host RBCs for nutrient uptake and waste disposal but also consumes hemoglobin of
host RBCs forming hemozoin crystals.23 Associated with these biochemical changes, the
host RBCs undergo biophysical modifications of electrical,10 optical,24 mechanical,24, 25
and magnetic26 properties. The first application of EI measurement in physiological
characterization for P. falciparum iRBCs (Pf-iRBCs) was performed using the cell–substrate
interaction sensing.10 The measurement was performed at the late intra-erythrocytic
development stage. It also relied on a special method to trap RBCs based on antigen/
antibody cross-linking and a self-assembled monolayer thus significantly limiting test
throughputs. A recent work on single cell EI detection of mature stage Pf-iRBCs was
realized based on conductance changes and characteristic dwell time using a graphene
transistor integrated in a microfluidic channel.27 The sensing was carried out in a “flow-
catch-release” mode via bio-recognition protein functionalization on the graphene surface.
Still, a high throughput (continuous flow detection) and high sensitivity diagnostic method
for detecting P. falciparum infection, especially intraerythrocytic asexual ring stage, is
necessary for field diagnostic tests and such a method is currently not available.
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In this paper, we demonstrate an electric impedance microflow cytometry (EIMC) platform
for reliable differentiation of each asexual maturation stage of Pf-iRBC. The EIMC platform
is featured with continuous blood flow measurement without any cell immobilization
treatment, target labelling, or electrode modification using bio-recognition elements. The
performance of the EIMC system was tested with Pf-iRBCs. We considered both
components of EI measurement of Pf-iRBCs, i.e. magnitude and phase, to establish a novel
evaluation parameter for discrimination of different disease states.
Materials and Methods
P. falciparum Culture and Sample Preparation
P. falciparum was cultured in leukocyte-free human RBCs (Research Blood Components,
Brighton, MA) under an atmosphere of 5% CO2 balanced with N2, at 5% hematocrit in
RPMI culture medium 1640 (Gibco Life Technologies) supplemented with 25 mM HEPES
(Sigma), 200 mM hypoxanthine (Sigma), 0.20% NaHCO3 (Sigma) and 0.25% Albumax II
(Gibco Life Technologies). The cultured P. falciparum sample prior to EIMC measurement
consisted of a mixture of multi-stage Pf-iRBCs and uninfected RBCs at parasitemia of 5% to
8%.
The working solution for EI measurement was phosphate-buffered saline (PBS; 2.67 mmol/l
KCl, 1.47 mmol/l KH2PO4, 137.93 mmol/l NaCl, 8.06 mmol/l Na2HPO4.7H2O) mixed with
Bovine Serum Albumin (BSA) (Sigma-Aldrich, St Louis, MO) to maintain osmotic pressure
and prevent RBC adhesion to the microfluidic channel. Three concentrations of BSA-PBS,
0.2%, 0.5%, and 1% weight/volume (w/v) were utilized in the experiments to achieve
optimum performance and sensitivity of EI measurement. The cultured P. falciparum
samples were cooled down to room temperature after being removed from the incubator,
then washed with PBS solution at 2000 rpm for 5 minutes at 21 °C and diluted by 200 times
in the working solution.
Microfluidic EIMC System
The experimental setup for EI measurement is shown in Fig. 1. The proposed microfluidic
device for EI measurement consists of a microfluidic channel integrated with Ti/Au
electrodes. The Ti/Au electrode of 10 nm/100 nm thickness was deposited on thin glass
substrate (500 μm) using E-beam vaporization and standard microfabrication techniques.
The microfluidic channel was fabricated using poly (dimethylsiloxane) PDMS casting
protocols and bonded to the glass substrate. The two electrodes were 20 μm wide with 20
μm spacing embedded in the narrowest portion of the microfluidic channel (30 μm × 5 μm
cross-sectional area) to probe individual human RBCs. The microfluidic EIMC system
exhibited excellent optical qualities, allowing direct observation via microscopy.
Measurements were performed on an Olympus IX 71 inverted microscope using a halogen
source (100 W). Identification of Pf-iRBCs and specific stage was achieved using a long
working distance lens with 100× magnification and numerical aperture NA = 0.8 (Olympus
LMPLFLN100X). The electrodes were connected with an E4980A precision LCR meter
(Agilent Technology, Inc.) for EI measurement. Communication between the LCR meter
and data-recording computer was realized through a Keithley KUSB-488A USB-to-GPIB
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cable. To reduce the error due to stray capacitance, the wires were connected in shielded
two-terminal configuration. Lab-VIEW software (National Instruments Corp., Austin, TX)
was used for automatic data acquisition.
The biochemical alterations during the multi-stage life cycle of P. falciparum lead to
corresponding transitions in electrical properties of the host RBCs. As indicated by the
equivalent circuit model of single Pf-iRBC suspended between two electrodes (see
Supplementary Fig. S1(b), similar to the classic circuit model of single cells),1, 20 the cell
membrane capacitance shields the cell interior from the external electric field at low
frequencies. At higher frequencies, owing to the short-circuiting effect of membrane
capacitance, the electric field penetrates to the cellular interior and reaches the parasite. The
present EI measurement was performed under a single frequency of 2 MHz with sampling
rate of 50 Hz in order to probe both interfacial and intracellular changes of Pf-iRBCs. The
frequency falls into the β dispersion regime (usually within the range of 0.1~10 MHz)28
where the large discrepancy in conductivity of cellular membrane and cytoplasm causes a
lag in charging response of the intracellular and extracellular substances. A continuous
steady flow of evenly distributed cell suspension was generated by an exterior pressure
gradient from two water columns, allowing minimum hydrodynamic disturbance during EI
measurement while maintaining sufficient signal sampling. A stream of individual cell is
managed where cells cross over electrodes with minimum bias from the midstream in order
to maintain steady detection signal.
Results
The proposed EIMC system possesses a cell-counting function. When a cell approaches and
crosses the electrodes, the presence of the cell at the measuring zone forms a lossy capacitor,
creating a dynamic impedance transition ΔZ from the base impedance of the system. The EI
transition is given by,
(1)
which is a complex function of cellular impedance ZPf–iRBC and medium impedance Zs with
the effects from the electric double layer (EDL) at the medium-electrode interfaces excluded
(see Supplementary Fig. S1(c)). The magnitude deviation ΔM and the phase deviation Δφ
are taken from the peaks of each ΔZ transition, and they are complex functions of cell size,
composition, dielectric properties of cytoplasm and the cell membrane, and the enclosure of
the medium surrounding the cell.
Fig. 2 shows a typical example of EI transitions measured when cells cross the electrodes
(see Supplementary Table S1 for EI transition statistics). Magnitude and phase changes, ΔM
and Δφ, are shown in subplots. The insert in the phase change subplot displays a
representative image for each sub-population, from uninfected RBCs to ring stage,
trophozoite stage, and schizont stage.
In order to systematically evaluate different experimental conditions, EI transitions were
normalized separately by,
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where  and  are the mean values of the magnitude change the phase change of 120
uninfected RBCs for the each corresponding BSA concentration (see Supplementary Table
S1).
Detection of P. falciparum infection of RBCs was possible but limited based on either one
of the normalized EI components in isolation. For 0.2% w/v BSA-PBS as demonstrated in
Fig. 3, the normalized magnitude transition monotonically increases with the progressive
malaria infection stages. The trend was not observed in normalized phase transition.
Additionally, for higher BSA concentration conditions (0.5% w/v and 1% w/v), no
consistent trends were found in either of the two normalized EI components as demonstrated
in Supplementary Figs. S2 and S3. Fig. 3 shows statistically significant differences (P <
0.001) in normalized EI magnitude between all three stages of Pf-iRBCs and uninfected
RBCs, although no significant differences can be found between two adjacent Pf-iRBC
stages.
In order to improve the disease state differentiation, we have established a new composite
evaluation parameter to detect Pf-iRBCs at different stages. As Fig. 4(a) shows, the
normalized EI components of uninfected RBCs at each BSA concentration can be well-fitted
with linear curves as indicated by solid lines in the scatter plot. In Fig. 4(b), ring stage Pf-
iRBCs are located in a slightly higher magnitude-phase region than the uninfected ones, and
the late trophozoite and schizont Pf-iRBCs are obviously away from the other populations.
In order to quantify this separation, we introduced a new dimensionless parameter, EI offset
δ, as the distance from each data point to the reference line,
(4)
where k and a are the linear interpolation coefficients of the normalized impedance
transitions of uninfected RBCs; xn and yn are the normalized impedance transitions of
individual RBCs. Although the normalized EI transitions varied between different
experiments due to slight variations in sample and device preparation, a similar scatter
pattern was observed. To combine data from each experiment, the scatter plots of EI
transitions for Pf-iRBCs at various stages were aligned to have a common uninfected RBC
reference line.
EI offsets δ for various Pf-iRBC stages were compared to the uninfected RBCs using
statistical box charts for different BSA concentrations, shown in Fig. 5. The statistical
analysis was carried out using a two-sample t-test (see Supplementary Tables S2-S4). When
BSA concentration was 0.2% w/v, all intraerythrocytic stages of Pf-iRBCs showed a
statistically significant difference (P < 0.001), as indicated in Fig. 5(a). With a small
increase of BSA concentration to 0.5% w/v, all stages of Pf-iRBCs were still statistically
different (P < 0.001). When BSA concentration increases further to 1% w/v, the ring stage
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bears moderate statistical significance (P = 0.134) despite trophozoite and schizont stages
still having high statistical significance (P < 0.001). It is clear that the offset δ is more
scattered at higher BSA concentrations. In addition, the overlap between uninfected RBCs
and Pf-iRBCs, especially for ring and trophozoite stages increases with BSA concentration.
As shown in Fig. 5(a), we also found that, at 0.2% w/v, our new EI measurement method
can be used to effectively distinguish Pf-iRBCs between adjacent asexual stages
(trophozoite vs. ring, and schizont vs trophozoite) with high statistical significance.
Discussion
One of the major challenges in non-invasive malaria diagnostics has been the lack of
effective differentiation strategy of early stage Pf-iRBCs from uninfected RBCs. With the
careful exploration of the optimum differentiation conditions, as shown in Fig. 3(a), using
0.2% w/v BSA-PBS, a statistically significant difference can now be found between ring
stage Pf-iRBCs and uninfected RBCs, which had not been achieved in earlier studies using
EI measurements.10, 27
We also recognized that BSA concentration may play an important role in separation of Pf-
iRBCs from uninfected RBCs. Pf-iRBCs at mature stages (trophozoite and schizont) have
elevated expression of membrane proteins [PfEMP]-1, forming surface protrusions or
“knobs,”29 which bear a positive charge (+20 mV) as indicated by Surface Potential
Spectroscopy.30 The difference in the magnitude of EI transitions decreases with BSA
concentration among various Pf-iRBC stages. This suggests that adsorption of negatively
charged BSA31 on the membrane of RBCs negates the surface charge modification
associated with “knobs.” As a consequence, the inherent difference in surface charge density
between different Pf-iRBC stages is likely to be minimized. This finding suggests that the
lowest BSA concentration we tested, 0.2% w/v, was an optimum condition of the present
EIMC system for P. falciparum diagnostic purposes while maintaining continuous flow of
cells. Lower BSA concentration than 0.2% w/v may result in adhesion of cells to the channel
walls and consequently ineffective or even impossible EI data collection.
Using the new parameter, EI offset δ, we have demonstrated significantly improved
resolution and effectiveness in the detection of Pf-iRBCs and among various
intraerythrocytic asexual stages using single frequency excitation. The consistent linear
interpolation between the normalized magnitude and phase transitions of uninfected RBCs
establishes a reliable base line. This reference line is carefully chosen to be the mean trend
of the measurements from uninfected cells; however, it can be the mean trend from entire
population at field diagnostic applications since uninfected RBC population is always
dominant (> 90%), even in severe malaria cases.32
Studies of cell impedance had enabled a possible label-free diagnostic test by recourse to the
measurement of specific parameters.33 However, systematic demonstration of the evolution
of cell pathological states has thus far not been reported. Indeed, accurate measurements of
biophysical properties of a cell in a microfluidic device is usually limited by such factors as
the high impedance of probe electrodes, stray capacitance, and electric double layer
capacitance. In addition, the presence of the intra-erythrocytic parasite also alters the
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progressive evolution of the electric response of the cell. In light of these issues, well-
controlled and systematic experiments linking cell electrical response from healthy to early
disease states to fully pathological states have thus far not been fully successful.
In this paper, we have overcome these limitations by establishing a new parameter, EI offset
δ, which contains both magnitude and phase information of the entire cell suspended in the
medium. This parameter appears to provide a promising new marker for identifying the
onset and progression of disease states at the cell level. By properly accounting for both EI
magnitude and phase information, the single offset parameter enables the identification of
progressive changes in the pathological state of a red blood cell invaded by the parasite. The
improved detectability of the subtle differences between disease states (e.g. P. falciparum
ring stage iRBCs versus uninfected RBCs) suggests that the EIMC system presented in this
study may be adapted for improving disease state differentiation of different cell populations
and other disease classes involving electrical property changes. Sickle cell anemia and
acidosis are among the diseases that are likely to have changes in EI properties of RBCs, and
would be interesting topics of future systematic studies. By using the changes in electrical
signature to identify the evolution of cell disease states, the present method provides an
additional tool to recent advances whereby changes in mechanical signature34, 35 or
membrane flickering24 have been linked as markers to detect cell disease states. To advance
the state of the art and overcome any remaining limitations, more systematic efforts need to
be carried out for practical medical applications.
Conclusion
The proposed microfluidic EIMC system provides a non-invasive and reliable detection
method for P. falciparum infection. The detection of P. falciparum ring stage iRBCs in
0.2% BSA-PBS medium was achieved using normalized EI magnitude. Furthermore, with a
newly developed dimensionless parameter, EI offset δ, the ring-stage Pf-iRBC detection was
significantly improved. Statistically significant differentiation of Pf-iRBCs was also
achieved between adjacent intraerythrocytic maturation stages (trophozoite vs. ring, and
schizont vs trophozoite). The sensitivity of the Pf-iRBC detection and EIMC performance
were found to be significantly influenced by BSA concentration and a number of other
relevant factors, such as cell concentration, flow rate, sampling rate. The results indicate that
0.2% w/v BSA in PBS is optimum for the present EIMC measurement with sufficient
detection sensitivity while minimizing cell adhesion to microfluidic channel. The newly
developed method using the composite parameter δ, instead of the single EI component
approach in an approximated circuit model, is also expected to be more broadly applicable
in differentiating other types of diseased cells for disease diagnostics and cell separation.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Experimental EIMC system setup for Pf-iRBC detection using microfluidic device.
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EI transitions measured as uninfected RBCs and Pf-iRBCs crossed over the electrode probe.
Measurement conditions: 2MHz 1V and 0.2% w/v BSA-PBS.
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(a) Scatter plot of normalized magnitude transition for uninfected RBCs and Pf-iRBCs in
0.2% w/v BSA-PBS. (b) Scatter plot of normalized phase transition for uninfected RBCs
and Pf-iRBCs in 0.2% w/v BSA-PBS.
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(a) Scatter plot of normalized EI transitions of uninfected RBCs. (b) Scatter plot of
normalized EI transitions for 0.2% BSA-PBS and definition of Offset δ.
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Pf-iRBC separation results in (a) 0.2% w/v BSA-PBS, (b) 0.5% w/v BSA-PBS, and (c) 1%
w/v BSA-PBS.
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